Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy
Planas Morin, J., Celma Domenech, A., Placer Santos, J., Trilla Herrera, E., Salvador Lacambra, C., Lorente Garcia, D., Regis, L., Carles Galceran, J., Morote Robles, J.
Published in Rheumatology international (01.10.2014)
Published in Rheumatology international (01.10.2014)
Get full text
Journal Article
1812P Exploration of germline (g) vs somatic (s) origin of homologous recombination repair (HRR) gene alterations and potential associations with antitumor activity in the HRR-deficient population from TALAPRO-2
Yip, S.M., Fizazi, K., Matsubara, N., Azad, A.A., Joung, J.Y., Fong, P.C., Carles Galceran, J., De Giorgi, U.F.F., Jones, R.J., Liu, G., Fay, A.P., Voog, E., Zschäbitz, S., Oldenburg, J., Di Santo, N., Healy, C.G., Lin, X., Laird, D., Agarwal, N.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1811P Patient-reported outcomes (PROs) in men with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) mutations receiving talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA: Results from a phase III (TALAPRO-2) study
Fay, A.P., Fizazi, K., Matsubara, N., Azad, A.A., Saad, F., De Giorgi, U.F.F., Joung, J.Y., Fong, P.C., Jones, R.J., Zschäbitz, S., Oldenburg, J., Shore, N.D., Dunshee, C., Carles Galceran, J., Cislo, P., Chang, J., Healy, C.G., Niyazov, A., Agarwal, N.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2385P Long-term survival upon anti-PD-(L)1 monotherapy in metastatic urothelial cancer (mUC): A multicenter retrospective study
Stockem, C.F., Einerhand, S., Miras Rodriguez, I., Perez Valderrama, B., Vulsteke, C., De Meulenaere, A.M., Morales Barrera, R., Carles Galceran, J., Giannatempo, P., Rametta, A., Bottelli, A., Lefort, F., Bakaloudi, D.R., Talukder, R., Grivas, P., van der Heijden, M.S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1367P JNJ-70218902 (JNJ-902), a TMEFF2 x CD3 bispecific antibody, in prostate cancer: Initial results from a phase I dose escalation study
Calvo, E., Doger de Spéville, B., Carles Galceran, J., Peer, A., Sarid, D.L., Eigl, B.J., Avadhani, A., Yao, D., Lin, V., Wu, S., Jaiprasart, P., Loffredo, J., Tamegnon, M., Xie, H., Hansen, A.R.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
294P Adult population with BRAF-mutated (BRAFmut) and NF1-mutated (NF1mut) gliomas. Analysis of the potential role of targeted therapy (TT) in these patients (pts)
Lostes Bardaji, M.J., Rezqallah Aron, M.A., Gonzalez Rodriguez, M., Villacampa Javierre, G., Martinez Saez, E., Auger, C., Maldonado, X., Martinez Ricarte, F., Tabernero, J., Carles Galceran, J., Garralda, E., Vieito Villar, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
503MO Real-world clinical and genomic characterization of gliomas: Predictive and prognostic insights
Mirallas, O., Velilla, G., Ruiz-Pace, F., Yaringaño, J.G., Gorria, T., Gomez-Puerto, D., Martínez, Á., Valbuena, D.E. López, Vaz Salgado, M.A., Gonzalez, A. Hernandez, Sorolla, M. Aguado, Raskina, K., Rodriguez, M. Gonzalez, Garcia, M. Martinez, Galceran, J. Carles, Balana, C., Pineda, E., Dienstmann, R., Sánchez, J.M. Sepúlveda, Villar, M. Vieito
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2144P The PRognostic Oncologic Plantology (PROP) website tool predicts 30-day mortality in hospitalized cancer patients on treatment
Mirallas, O., Cullell, B. Martin, Navarro, V., Pedrola, A., Cano, K.S. Vega, Recuero-Borau, J., Salva, C., Valbuena, D.E. López, Puerto, D.A. Gomez, Beltran, J. Sanz, Hermida, J.M. Ucha, Lores, G. Molina, Roca, M., Saiz, A. Peñuelas, Serradell, S., Tabernero, J., Tormo, S. Servitja, Paez, D., Dienstmann, R., Galceran, J. Carles
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
538P Single-center retrospective analysis of patients with brain metastases included in early phase clinical trials
Pretelli, G., Laimito, K.I. Rojas, Alonso, G., Bardaji, M.J. Lostes, Calvo, A. Hernando, Galvao, V., Oberoi, A., Morillo, B. Ortega, Santa Gadea, O. Saavedra, Moya, J. Ginard, Manich, C. Saura, Fernandez, M.E. Elez, Ortiz, C., Couselo, E. Muñoz, Braña, I., Perez, A. Callejo, Galceran, J. Carles, Felip, E., Garralda, E., Villar, M. Vieito
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2055P Multidisciplinary Tumor-ICU Board: Enhancing care for critically Ill patients with solid tumors in the ICU
Montana, F.J. Ros, Gonzalez, N. Saoudi, Salazar, S.A. Bueno, Diaz, C., Vega, S., Albasanz, A., Company, J. Aguilar, Gallardo, P., Pardo, P. Gomez, Herrera, M. Roca, Eremiev, S., Mascaro, P., Buch, P.B., Yaringaño, J.G., Ortiz, C., Galceran, J. Carles, Ruiz, I., Ferrer, R., Fernandez, M.E. Elez
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
702P Characterization of germline HLA genotypes in patients (pts) with solid tumors treated with immunotherapy
Rojas Laimito, K.I., Vieito Villar, M., Moya Hernández, M.Á., Pretelli, G., Lostes Bardaji, M.J., Saavedra Santa Gadea, O., Hernando Calvo, A., Galvao, V., Oberoi, A., Alonso, G., Braña, I., Ginard Moya, J., Baraibar Argota, I., Saura Manich, C., Muñoz Couselo, E., Macarulla, T., Garcia Duran, C., Carles Galceran, J., Tabernero, J., Garralda, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2137P Impact of supportive care on the quality of life (QoL) of hospitalized cancer patients (pts)
Beltran, J. Sanz, Mirallas, O., Bosma, F., Pérez, M.A. Molina, Salva, C., Cano, K.S. Vega, Puerto, D.A. Gomez, Valbuena, D.E. López, Hermida, J.M. Ucha, Lores, G. Molina, Herrera, M. Roca, Sahun, C. Sola, Montenegro, D. Romero, Serradell, S., Paez, D., Galceran, J. Carles, Cullell, B. Martin
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1783P PROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Efficacy results from the pilot phase
Arranz Arija, J.A., Piulats Rodriguez, J.M., Vazquez Estevez, S., Sepúlveda Sánchez, J.M., Alonso Gordoa, T., Perez Valderrama, B., Sala González, N., Climent Duran, M.A., Gallardo Diaz, E., Rodriguez-Vida, A., Caballero Diaz, C., Puente, J., Mendez Vidal, M.J., Parra, E.M.F., Martín, R.C., Virizuela Echaburu, J.A., Gragera, M.B.G., García Sanchez, J., García-Carbonero, I., Carles Galceran, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1807P Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Subgroup analyses of the all-comers cohort from TALAPRO-2 by homologous recombination repair (HRR) status
Matsubara, N., Fizazi, K., Azad, A.A., Carles Galceran, J., Fay, A.P., De Giorgi, U.F.F., Joung, J.Y., Fong, P.C., Voog, E., Jones, R.J., Shore, N.D., Dunshee, C., Zschäbitz, S., Karsh, L.I., Barthelemy, P., Lin, X., Healy, C.G., Di Santo, N., Zohren, F., Agarwal, N.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2314P Quality and safety of research biopsies (RB) in oncology clinical trials
Nuciforo, P.G., Ruiz-Pace, F., Jimenez, J., Comas, R., Fasani, R., Viaplana, C., Sevillano, C., Martinez, P., Créixams, X. Serres, Manich, C. Saura, Fernandez, M.E. Elez, Oaknin, A., Braña, I., Couselo, E. Muñoz, Macarulla, T., Galceran, J. Carles, Tabernero, J., Felip, E., Garralda, E., Dienstmann, R.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
290P Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT)
Mirallas, O., López Valbuena, D.E., Yaringaño, J., Martin Cullell, B., Illescas, D.G., Aguilar Izquierdo, S., Martínez-Sáez, E., Pedrola, A., Vivancos, A., Saoudi Gonzalez, N., Ros Montana, F.J., Gonzalez Rodriguez, M., Dienstmann, R., Mateo, J., Tabernero, J., Garralda, E., Carles Galceran, J., Vieito Villar, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1421P Effect of abiraterone-prednisone in metastatic castration-sensitive prostate cancer (mCSPC) with neuroendocrine and very high-risk features in the PEACE-1 trial
Bernard-Tessier, A., Cancel, M., Tombal, B., Roubaud, G., Carles Galceran, J., Flechon, A., McDermott, R.S., Supiot, S., Berthold, D.R., Philippe, R., Kacso, G., Gravis Mescam, G., Calabrò, F., Berdah, J.F., Hasbini, A., Ricci, F., Hennequin, C., Ribault, H., Foulon, S., Fizazi, K.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
2540 Experience with radium-223 as a systemic treatment for patients (pts) with castration-resistant prostate cancer (CRPC) out of a clinical trial in Spain
Grande, E, Pinto, A, Dur´n, I, López-Criado, P, Su´rez, C, Gonz´lez-Larriba, J.L, S´nchez-Lorenzo, L, Maroto, P, L´inez, N, Gonz´lez del Alba, A, S´ez, M.I, Alonso-Gordoa, T, Pérez-Valderrama, B, Puente, J, Morales, R, Esteban, E, Manneh, R, Benedetti, J, Carles-Galcerán, J, Castellano, D
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
625P TMPRSS2-ERG expression and clinical evolution of metastatic hormone sensitive prostate cancer
Aversa, C., Jimenez, N., Marín-Aguilera, M., Ferrer, L., Rodríguez-Carunchio, L., Diaz-Mercedes, S., Font Pous, A., Rodriguez-Vida, A., Domenech Santasusana, M., Figols Gorina, M., Climent Duran, M.A., Cros Costa, S., Chirivella, I., Herrero Rivera, D., Gonzalez-Billalabeitia, E., Jiménez-Peralta, D., Carles Galceran, J., Suarez Rodriguez, C., Reig Torras, O., Mellado, B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1623P Phase I clinical trials (CT) forge on despite COVID-19
Bardaji, M.J. Lostes, Aliende, E., Moreno, M., Oberoi, H.K., Braña, I., Saavedra, O., Villar, M. Vieito, Alonso, G., Galvao, V., Carballo, N., Beltran, M., Rovira, P., Cidoncha, I., Manich, C. Saura, Mercade, T. Macarulla, Oaknin, A., Galceran, J. Carles, Felip, E., Garralda, E., Pujol, S. Perez
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article